You have 9 free searches left this month | for more free features.

Hylenex

Showing 1 - 25 of 38

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Muscle Spasticity Trial in Baltimore (Hyaluronidase, Placebo)

Recruiting
  • Muscle Spasticity
  • Baltimore, Maryland
    Paria Arfa Fatollahkhani, MD, M.Sc.
Oct 28, 2022

Healthy Volunteers Trial in Philadelphia (dMAb AZD5396, dMAb AZD8076, Electroporation device)

Recruiting
  • Healthy Volunteers
  • dMAb AZD5396
  • +4 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Nov 16, 2022

Healthy Volunteers Trial in Philadelphia (INO-A002, CELLECTRA® 2000, Dengue Fever Antibodies (IgG))

Completed
  • Healthy Volunteers
  • INO-A002
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Nov 7, 2022

Type 1 Diabetes Trial in Stanford (Hyaluronidase, Control)

Completed
  • Type 1 Diabetes Mellitus
  • Stanford, California
    Stanford University
Sep 24, 2019

Dehydration Trial in Luanda (Hyaluronic Acid)

Completed
  • Dehydration
  • Hyaluronic Acid
  • Luanda, Kenya
    Sagam Community Hospital
Mar 5, 2019

Psoriasis Trial in San Diego (Hylenex, Normal Saline)

Completed
  • Psoriasis
  • Hylenex
  • Normal Saline
  • San Diego, California
    UCSD Division of Dermatology
Dec 28, 2018

Chronic Wounds Trial in Harbin (HA35(L20200708MP07707, Ministry of Health, Mongolia)was freshly manufactured by mixing

Completed
  • Chronic Wounds
  • HA35(L20200708MP07707, Ministry of Health, Mongolia)was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089)
  • Harbin, Heilongjiang, China
    Far East Hospital
Mar 1, 2023

Healthy Trial in Kalamazoo (recombinant human hyaluronidase)

Completed
  • Healthy
  • recombinant human hyaluronidase
  • Kalamazoo, Michigan
    Jasper Clinic
Sep 18, 2018

Outcomes Study (FIGARO)

Completed
  • Primary Immunodeficiency
  • Secondary Immune Deficiency
  • HyQvia
  • Paris, France
  • +3 more
Mar 18, 2022

Type 1 Diabetes Trial in Chula Vista (Sham Injection, Recombinant human hyaluronidase PH20, Insulin aspart)

Completed
  • Type 1 Diabetes Mellitus
  • Sham Injection
  • +3 more
  • Chula Vista, California
    Profil Institute for Clinical Research
Feb 5, 2019

Type 1 Diabetes Trial in Chula Vista (Rapid Acting insulin with pre-treatment of rHuPH20, Sham injection)

Completed
  • Type 1 Diabetes Mellitus
  • Rapid Acting insulin with pre-treatment of rHuPH20
  • Sham injection
  • Chula Vista, California
    Profil Institute for Clinical Research
Jan 30, 2019

Type 1 Diabetes Trial in Chula Vista (Humalog, Humulin-R, Recombinant human hyaluronidase PH20 (rHuPH20))

Completed
  • Type 1 Diabetes Mellitus
  • Chula Vista, California
    Profil Institute for Clinical Research, Inc.
Feb 4, 2019

Diabetes Trial in San Antonio (Humalog, Humulin-R, Recombinant human hyaluronidase PH20 (rHuPH20))

Completed
  • Diabetes Mellitus
  • San Antonio, Texas
    Diabetes and Glandular Disease Research, Inc.
Feb 4, 2019

Type 1 Diabetes Trial in United States (Commercial Hylenex® recombinant (hyaluronidase human injection), Precommercial Hylenex

Completed
  • Type 1 Diabetes Mellitus
  • Commercial Hylenex® recombinant (hyaluronidase human injection)
  • +4 more
  • Concord, California
  • +38 more
Oct 10, 2018

Dehydration Trial in United States (recombinant human hyaluronidase)

Completed
  • Dehydration
  • recombinant human hyaluronidase
  • Hartford, Connecticut
  • +24 more
Oct 10, 2018

Dehydration, Cardiac Output, Pediatrics Trial in Nashville (Hylenex)

Completed
  • Dehydration
  • +2 more
  • Hylenex
  • Nashville, Tennessee
    Monroe Carell Jr. Children's Hospital at Vanderbilt
Jan 8, 2018

Diabetes, Type 1 Trial in United States (Insulin lispro, recombinant human hyaluronidase PH20, Insulin aspart)

Completed
  • Diabetes Mellitus, Type 1
  • Insulin lispro
  • +4 more
  • Escondido, California
  • +18 more
Feb 5, 2019

Dermal Filler Trial (Hylenex)

Completed
  • Dermal Filler
  • Hylenex
  • (no location specified)
May 15, 2017

Dehydration Trial (Oral rehydration fluid, Isotonic hydration fluid and recombinant human hyaluronidase)

Withdrawn
  • Dehydration
  • Oral rehydration fluid
  • Isotonic hydration fluid and recombinant human hyaluronidase
  • (no location specified)
May 5, 2017

Healthy Volunteers Trial in San Antonio (rHuPH20, Insulin Human Injection, Insulin Lispro Injection)

Completed
  • Healthy Volunteers
  • San Antonio, Texas
    dgd Research, Inc.
Aug 14, 2018

Type 1 Diabetes Trial in Chula Vista (Insulin aspart, Recombinant human hyaluronidase PH20 (rHuPH20))

Completed
  • Type 1 Diabetes Mellitus
  • Insulin aspart
  • Recombinant human hyaluronidase PH20 (rHuPH20)
  • Chula Vista, California
    Profil Institute for Clinical Research
Jun 26, 2014

Healthy Trial in Chula Vista (Recombinant human hyaluronidase PH20 (rHuPH20), Insulin lispro, Insulin glulisine)

Completed
  • Healthy
  • Recombinant human hyaluronidase PH20 (rHuPH20)
  • +3 more
  • Chula Vista, California
    Profil Institute for Clinical Research, Inc.
Jun 12, 2014

Diabetes, Type 1 Trial in United States (Insulin Lispro, regular human insulin, recombinant human hyaluronidase PH20)

Completed
  • Diabetes Mellitus, Type 1
  • Insulin Lispro
  • +3 more
  • Aurora, Colorado
  • +7 more
Aug 28, 2014

Diabetes Trial in Chula Vista (Insulin Lispro, Regular Human Insulin, rHuPH20)

Completed
  • Diabetes Mellitus
  • Insulin Lispro
  • +2 more
  • Chula Vista, California
    Profil Institute for Clinical Research, Inc.
Jul 11, 2014

Diabetes, Type 2 Trial in Chula Vista (Humalog, Humulin-R, Recombinant human hyaluronidase PH20 (rHuPH20))

Completed
  • Diabetes Mellitus, Type 2
  • Chula Vista, California
    Profil Institute for Clinical Research, Inc.
Jul 30, 2014